These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
386 related items for PubMed ID: 26786982
1. Outcomes of Medical and Surgical Therapy for Entero-urinary Fistulas in Crohn's Disease. Taxonera C, Barreiro-de-Acosta M, Bastida G, Martinez-Gonzalez J, Merino O, García-Sánchez V, Gisbert JP, Marín-Jiménez I, López-Serrano P, Gómez-García M, Iglesias E, Lopez-Sanroman A, Chaparro M, Saro C, Bermejo F, Pérez-Carazo L, Plaza R, Olivares D, Alba C, Mendoza JL, Fernández-Blanco I. J Crohns Colitis; 2016 Jun; 10(6):657-62. PubMed ID: 26786982 [Abstract] [Full Text] [Related]
7. The respective role of medical and surgical therapy for enterovesical fistula in Crohn's disease. Zhang W, Zhu W, Li Y, Zuo L, Wang H, Li N, Li J. J Clin Gastroenterol; 2014 Sep; 48(8):708-11. PubMed ID: 24457944 [Abstract] [Full Text] [Related]
8. Genital fistulas in female Crohn's disease patients.: clinical characteristics and response to therapy. de la Poza G, López-Sanroman A, Taxonera C, Marín-Jimenez I, Gisbert JP, Bermejo F, Opio V, Muriel A. J Crohns Colitis; 2012 Apr; 6(3):276-80. PubMed ID: 22405162 [Abstract] [Full Text] [Related]
9. Efficacy of combined anti-TNF-alpha and surgical therapy in perianal and enterocutaneous fistulizing Crohn's disease--clinical observations from a tertiary Eastern European center. Bor R, Farkas K, Bálint A, Szucs M, Ábrahám S, Baradnay G, Wittmann T, Szepes Z, Nagy F, Molnár T. Scand J Gastroenterol; 2015 Feb; 50(2):182-7. PubMed ID: 25384713 [Abstract] [Full Text] [Related]
10. Anti-TNF Monotherapy for Crohn's Disease: a 13-year Multicentre Experience. Peyrin-Biroulet L, Salleron J, Filippi J, Reenaers C, Antunes O, Filipe V, Louis E, Hébuterne X, Roblin X. J Crohns Colitis; 2016 May; 10(5):516-24. PubMed ID: 26802084 [Abstract] [Full Text] [Related]
11. Type of fistula determines response to infliximab in patients with fistulous Crohn's disease. Parsi MA, Lashner BA, Achkar JP, Connor JT, Brzezinski A. Am J Gastroenterol; 2004 Mar; 99(3):445-9. PubMed ID: 15056083 [Abstract] [Full Text] [Related]
12. Long-term outcome of enterocutaneous fistula in patients with Crohn's disease treated with anti-TNF therapy: a cohort study from the GETAID. Amiot A, Setakhr V, Seksik P, Allez M, Treton X, De Vos M, Laharie D, Colombel JF, Abitbol V, Reimund JM, Moreau J, Veyrac M, Flourié B, Cosnes J, Lemann M, Bouhnik Y. Am J Gastroenterol; 2014 Sep; 109(9):1443-9. PubMed ID: 25091063 [Abstract] [Full Text] [Related]
18. Long-term outcome of patients with Crohn's disease who discontinued infliximab therapy upon clinical remission. Papamichael K, Vande Casteele N, Gils A, Tops S, Hauenstein S, Singh S, Princen F, Van Assche G, Rutgeerts P, Vermeire S, Ferrante M. Clin Gastroenterol Hepatol; 2015 Jun; 13(6):1103-10. PubMed ID: 25478919 [Abstract] [Full Text] [Related]
19. Fistula response to methotrexate in Crohn's disease: a case series. Mahadevan U, Marion JF, Present DH. Aliment Pharmacol Ther; 2003 Nov 15; 18(10):1003-8. PubMed ID: 14616166 [Abstract] [Full Text] [Related]
20. Tumor Necrosis Factor Inhibitors May Have Limited Efficacy for Complex Perianal Fistulas Without Luminal Crohn's Disease. McCurdy JD, Parlow S, Dawkins Y, Samji K, Rhee GG, Oliveira L, Macdonald B, Sabri E, Murthy S. Dig Dis Sci; 2020 Jun 15; 65(6):1784-1789. PubMed ID: 31642006 [Abstract] [Full Text] [Related] Page: [Next] [New Search]